Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/09/19 → 3/09/24 |
Keywords
- clinical trial
- treatment efficacy
- prostate cancer
- phase 2 study
Clinical Trial Phase
- Phase II
A Phase 2 Trial of Nivolumab plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer
- Pook, David (Primary Chief Investigator (PCI))
Project: Research